Come up with a name for your new list and we'll add to it:
Civitas Therapeutics raised a round of funding on June 19, 2013. Investors include
The Michael J. Fox Foundation.
Civitas is a privately-held biopharmaceutical company focused on developing a pipeline of inhaled therapeutics with the clinically proven ARCUS dry powder pulmonary delivery platform. In addition to t…